>>>   Click for Diagenode’s approach to COVID-19


December 3, 2013

As the role of the changes in the epigenome is becoming more and more revealed there are a growing number of scientific papers reporting epigenetic/epigenomic studies. Malicious epigenomic alterations can be the reason behind widespread social problems like different types of cancers (eg. breast cancer), as well as rare diseases like ICF (Immunodeficiency, Centromeric region instability, Facial anomalies) syndrome, the like of which often not interest the medical industry therefore the diagnostic/therapeutic products are underdeveloped or non-existent at all. Such chromatin diseases (Rett syndrome, ATRX syndrome, FSHD, ICF syndrome) are the subject of the DisChrom project (FP7 project under the grant agreement PTN-GA-2009-238242) in which we participate.

Download the poster


  • DNA methylation workshop: Become an expert at RRBS
    Oct 1-Oct 31, 2021
  • Dutch Chromatin Meeting
    Radboud UMC, Geert Grooteplein 15, 6525 EZ Nijmegen, The Netherlands, Experience center, route 292 to 307
    Nov 12, 2021



The European Regional Development Fund and Wallonia are investing in your future.

Extension of industrial buildings and new laboratories.


       Site map   |   Contact us   |   Conditions of sales   |   Conditions of purchase   |   Privacy policy   |   Diagenode Diagnostics